MiP2014: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
* A3. Mitochondrial density and normalization of respiration – is there a general biochemical or molecular marker? | * A3. Mitochondrial density and normalization of respiration – is there a general biochemical or molecular marker? | ||
* A4. Biochemical reserve capacity, respiratory control ratios and coupling efficiency – are conventional concepts inconsistent? | * A4. Biochemical reserve capacity, respiratory control ratios and coupling efficiency – are conventional concepts inconsistent? | ||
=== B. Experimental protocols in mitochondrial biochemistry === | === B. Experimental protocols in mitochondrial biochemistry === | ||
* B1. Incubation media for mt-preparations and experimental temperature in functional studies of mammalian mitochondria – guided by concept or merely tradition? | * B1. Incubation media for mt-preparations and experimental temperature in functional studies of mammalian mitochondria – guided by concept or merely tradition? | ||
| Line 22: | Line 23: | ||
* C3. Availability and quality control of chemicals used in mitochondrial research – who controls? | * C3. Availability and quality control of chemicals used in mitochondrial research – who controls? | ||
* C4. Standards for the diagnosis of mitochondrial pathologies – a challenge for collaboration with mitochondrial organizations? | * C4. Standards for the diagnosis of mitochondrial pathologies – a challenge for collaboration with mitochondrial organizations? | ||
Particularly in view of Subtopic C, it may be attractive for mitochondrial organizations to send and support delegates. The conference will, therefore, provide a unique forum for international networking, and may inspire new national groups to be formed in contact with established mitochondrial organizations: | Particularly in view of Subtopic C, it may be attractive for mitochondrial organizations to send and support delegates. The conference will, therefore, provide a unique forum for international networking, and may inspire new national groups to be formed in contact with established mitochondrial organizations: | ||
>> '''[[MitoGlobal_Organizations]]''' | >> '''[[MitoGlobal_Organizations]]''' | ||
== International programme committee == | == International programme committee == | ||
The international programme committee will provide scientific input by active participation, nominate further invited speakers to ensure balanced point/counterpoint introductions, and select the abstracts as a basis for participation (restricted number of participants), for oral short presentations, and for flash presentations. | The international programme committee will provide scientific input by active participation, nominate further invited speakers to ensure balanced point/counterpoint introductions, and select the abstracts as a basis for participation (restricted number of participants), for oral short presentations, and for flash presentations. | ||
Chair: | Chair: | ||
* [[Gnaiger E|Gnaiger Erich]], Medical University Innsbruck, AT. - [email protected] | * [[Gnaiger E|Gnaiger Erich]], Medical University Innsbruck, AT. - [email protected] | ||
Members ''(confirmed)'': | |||
Members (confirmed): | |||
* [[Ali SS|Ali Sameh S]], Helmy Institute of Medical Sciences, Giza, Egypt | * [[Ali SS|Ali Sameh S]], Helmy Institute of Medical Sciences, Giza, Egypt | ||
* [[Borutaite V|Borutaite Vilma]], Lithuanian University of Health Sciences Kaunas, LT | * [[Borutaite V|Borutaite Vilma]], Lithuanian University of Health Sciences Kaunas, LT | ||
| Line 44: | Line 45: | ||
* [[Vercesi AE|Vercesi Anibal E]], State University of Campinas, Sao Paulo, Brazil | * [[Vercesi AE|Vercesi Anibal E]], State University of Campinas, Sao Paulo, Brazil | ||
* [[Taiwan Society for Mitochondrial Research and Medicine|Wei Yau-Huei]], Mackay Medical College, New Taipei City, Taiwan | * [[Taiwan Society for Mitochondrial Research and Medicine|Wei Yau-Huei]], Mackay Medical College, New Taipei City, Taiwan | ||
Members (invited): | * [[Zorzano A|Zorzano Antonio]], Universitat de Barcelona, Spain | ||
Members ''(invited)'': | |||
* [[Neurocon|Chakrabarti Sasanka]], Institute of Post-graduate Medical Education & Research, Kolkatta, India | * [[Neurocon|Chakrabarti Sasanka]], Institute of Post-graduate Medical Education & Research, Kolkatta, India | ||
* [[Chinese Society of Mitochondrial Research and Medicine|Chen Quan]], Chinese Academy of Sciences, Nankai University, Beijing | * [[Chinese Society of Mitochondrial Research and Medicine|Chen Quan]], Chinese Academy of Sciences, Nankai University, Beijing | ||
| Line 51: | Line 53: | ||
* Pecina Petr, Academy of Sciences of the Czech Republic, CZ | * Pecina Petr, Academy of Sciences of the Czech Republic, CZ | ||
* Tanaka Masashi, Toyko Metropolitan Institute of Gerontology, JP | * Tanaka Masashi, Toyko Metropolitan Institute of Gerontology, JP | ||
Revision as of 23:00, 2 September 2013
MiP2014: Mitochondrial Physiology - a Point/Counterpoint Meeting
The Mitochondrial Physiology Society, Obergurgl, Tyrol, Austria. 2014-Sep-08 to 12
Programme structure
In each of the 12 sessions a point/counterpoint introduction will be given by invited keynote speakers to provide a balanced overview and promote discussions. Short oral presentations are selected from abstracts, including student presentations. Rapid platform statements will introduce posters which contribute to a specific session. Posters are up throughout the meeting, and poster discussions are integrated into the platform sessions.
A. Mitochondrial respiratory control
- A1. mtDNA, mt-phenotype and disease – is there biochemical and molecular-genetic evidence to explain observed associations?
- A2. Fission and fusion, mitochondrial structure and function - is there a tight connection?
- A3. Mitochondrial density and normalization of respiration – is there a general biochemical or molecular marker?
- A4. Biochemical reserve capacity, respiratory control ratios and coupling efficiency – are conventional concepts inconsistent?
B. Experimental protocols in mitochondrial biochemistry
- B1. Incubation media for mt-preparations and experimental temperature in functional studies of mammalian mitochondria – guided by concept or merely tradition?
- B2. Intracellular oxygen pressure versus oxygen regimes in studies of ROS production and respiration - are mitochondria sources or sinks of ROS?
- B3. Quantitative measurement of mt-membrane potential - potentiometric/fluorometric.
- B4. Instrumental platforms in mitochondrial physiology – industrial presentations.
C. Towards quality assurance
- C1. Do blood cells versus muscle biopsies provide valid models for diagnosis of mitochondrial pathologies?
- C2. Integrity of mitochondrial preparations – is a consensus possible on quality control criteria?
- C3. Availability and quality control of chemicals used in mitochondrial research – who controls?
- C4. Standards for the diagnosis of mitochondrial pathologies – a challenge for collaboration with mitochondrial organizations?
Particularly in view of Subtopic C, it may be attractive for mitochondrial organizations to send and support delegates. The conference will, therefore, provide a unique forum for international networking, and may inspire new national groups to be formed in contact with established mitochondrial organizations:
>> MitoGlobal_Organizations
International programme committee
The international programme committee will provide scientific input by active participation, nominate further invited speakers to ensure balanced point/counterpoint introductions, and select the abstracts as a basis for participation (restricted number of participants), for oral short presentations, and for flash presentations.
Chair:
- Gnaiger Erich, Medical University Innsbruck, AT. - [email protected]
Members (confirmed):
- Ali Sameh S, Helmy Institute of Medical Sciences, Giza, Egypt
- Borutaite Vilma, Lithuanian University of Health Sciences Kaunas, LT
- Dela Flemming, University of Copenhagen, DK
- Duchen Michael R, University College London, UK
- Elmér Eskil, Lund University, SE
- Koopman Werner J, Radboud Univ Nijmegen Medical Centre, NL
- Neufer P Darrel, East Carolina University, Greenville, NC, US
- Ojuka Edward, University of Cape Town, South Africa
- Perry Christopher G, York University, Toronto, Canada
- Rossignol Rodrigue, Université Victor Segalen-Bordeaux, FR
- Vercesi Anibal E, State University of Campinas, Sao Paulo, Brazil
- Wei Yau-Huei, Mackay Medical College, New Taipei City, Taiwan
- Zorzano Antonio, Universitat de Barcelona, Spain
Members (invited):
- Chakrabarti Sasanka, Institute of Post-graduate Medical Education & Research, Kolkatta, India
- Chen Quan, Chinese Academy of Sciences, Nankai University, Beijing
- Haas Richard H, University of California San Diego, CA, USA
- Hickey Anthony J, University of Auckland, NZ
- Pecina Petr, Academy of Sciences of the Czech Republic, CZ
- Tanaka Masashi, Toyko Metropolitan Institute of Gerontology, JP
